Significant figures

Blueberries Medical Reports Q1-2023

Retrieved on: 
Tuesday, May 30, 2023
Workforce, Interim, Blueberry, COVID-19, Gustavo Gutiérrez, Significant figures, MBA, Accounting, Audit committee, Corporation, Cost, Knowledge, Growth, Mazda North American Operations, Financial management, Management, Audit, Biotechnology

By streamlining our workforce and aligning resources with commercial and revenue-generating activities, we have achieved significant savings in personnel-related costs.

Key Points: 
  • By streamlining our workforce and aligning resources with commercial and revenue-generating activities, we have achieved significant savings in personnel-related costs.
  • Director and management fees are incurred specifically for certain directors and officers of the Company for services provided to Blueberries either from themselves personally or through a related entity.
  • Blueberries Corporation is pleased to announce significant developments in its board of directors and leadership team, reflecting our commitment to fostering growth and maximizing our global potential.
  • In line with these structural changes, we are thrilled to announce the appointment of Gustavo Gutierrez as the new Country Manager of Blueberries SAS in Bogota, Colombia.

Arbor Biotechnologies Announces Presentations at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy

Retrieved on: 
Tuesday, May 2, 2023
Kidney disease, Abstract, HAO1, Gene, Waste, Significant figures, American Society of Gene and Cell Therapy, Model, PH, Primary hyperoxaluria, Engineering, Annual general meeting, Cell, Oxalate, Society, Vaccine

CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) --  Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that three abstracts were selected for poster presentation at the upcoming American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting being held from May 16-20, 2023, in Los Angeles, CA.

Key Points: 
  • CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) --  Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that three abstracts were selected for poster presentation at the upcoming American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting being held from May 16-20, 2023, in Los Angeles, CA.
  • “Among our poster presentations, we will be providing early results with our lead product candidate, ABR-001—a novel type V CRISPR Cas, which we are developing for the treatment of primary hyperoxaluria, or PH.
  • PH is a rare, life-threatening condition that prevents the kidneys from filtering fluids and waste products from the body effectively, often resulting in end-stage renal disease.
  • We are highly encouraged by these preclinical results, which demonstrate that in vivo editing of the HAO1 gene with ABR-001 significantly reduced toxic oxalates in a mouse model of PH Type 1.

American Battery Technology Company Releases First Fiscal Quarter FY2023 Financial Results

Retrieved on: 
Tuesday, November 15, 2022
Lithium, DuPont, Technology, U.S. Securities and Exchange Commission, Security (finance), State, ESG, Metal, Income, Significant figures, University, Consultant, Pilot plant, Acceleration, View, Company, DOE, Research, U.S. Department of Energy, Office of Inspector General, Multimedia, Investment, Annual report, Recycling, Private Securities Litigation Reform Act, U.S. Department of Defense Strategy for Operating in Cyberspace, Reno 1868 FC

RENO, Nev., Nov. 15, 2022 /PRNewswire/ -- American Battery Technology Company (ABTC) (OTCQB: ABML), an American critical battery materials company that is commercializing both its primary minerals manufacturing and secondary minerals lithium-ion battery recycling technologies, is pleased to announce financial results from its first fiscal quarter 2023, ending on September 30, 2022. 

Key Points: 
  • Increased Investment in the Acceleration of Its Critical Minerals Extraction Technologies, and Significant Reduction in Operating Costs, Reinforce Capabilities to Address Domestic Battery Metals Supply Shortages
    RENO, Nev., Nov. 15, 2022 /PRNewswire/ -- American Battery Technology Company (ABTC) (OTCQB: ABML), an American critical battery materials company that is commercializing both its primary minerals manufacturing and secondary minerals lithium-ion battery recycling technologies, is pleased to announce financial results from its first fiscal quarter 2023, ending on September 30, 2022.
  • ABTC expects the first fiscal quarter operating expenses to reflect its run-rate operating expenses, until the Pilot Plant begins operations.
  • American Battery Technology Company is uniquely positioned to supply low-cost, low-environmental impact, and domestically sourced battery metals through its three divisions: lithium-ion battery recycling, primary battery metal extraction technologies, and primary resources development.
  • Although the American Battery Technology Company's (the "Company) management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct.

Vislink Reports Second Quarter 2021 Financial Results

Retrieved on: 
Monday, August 16, 2021
CFO, Income, Sport, ATSC, EBITDA, APT, U.S. Department of Defense Strategy for Operating in Cyberspace, Nasdaq, Olympic Games, History, UEFA Euro 2020, CEO, Company, Intelligence, Private Securities Litigation Reform Act, DVE, COVID-19, Significant figures, Russell, Department, Alabama Public Television, GLOBE, IP, Department of Defense Architecture Framework, GAAP, SEC, Net, Acquisition, Webcast, Growth, Leadership, ISR, Budget, Knowledge, Collection, Depreciation, Common, Solution, Law enforcement, Animal, Video game, Risk management

Hackettstown, NJ, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Vislink (“the “Company”) (Nasdaq: VISL), a global technology in the capture, delivery and management of high quality, live video and associated data in the media & entertainment, law enforcement and defense markets, reported financial results for the quarter ended June 30, 2021, 2021. Company management will host a live webcast on Tuesday, August 17, 2021 at approximately 10:00 a.m. ET to review the Company’s financial and operating results and provide a general business update (see webcast details below).

Key Points: 
  • Ended the second quarter of 2021 with $55.5 million in cash and cash equivalents, compared to $60 million at the end of the first quarter of 2021.
  • Gross margins were 52.8% of revenue in the second quarter of 2021, compared to 46% in the first quarter of 2021.
  • Net loss attributable to common shareholders was $834,000, or $(0.02) per share in the second quarter of 2021 compared to a net loss of $2.7 million, or $(0.07) per share in the first quarter of 2021 and a net loss of $778,000, or $(0.05) per share in the second quarter of 2020.
  • We are very pleased to report revenues in the second quarter that were over 85% higher than the amount recorded in the first quarter of 2021, said Mickey Miller, CEO of Vislink.

GeoPark Announces Successful First Phase of Its Strategic Deleveraging Process

Retrieved on: 
Thursday, April 22, 2021
Oil, Gas, Energy, Arithmetic, Fields of mathematics, Articles, Academic disciplines, Numerical analysis, Computer arithmetic, Rounding, Theory of computation, Significant figures, Forward-looking statement

Percentage figures included in this press release have not in all cases been calculated based on such rounded figures but based on such amounts prior to rounding.

Key Points: 
  • Percentage figures included in this press release have not in all cases been calculated based on such rounded figures but based on such amounts prior to rounding.
  • For this reason, certain percentage amounts in this press release may vary from those obtained by performing the same calculations using the figures in the financial statements.
  • In addition, certain other amounts that appear in this press release may not sum due to rounding.\nThis press release contains statements that constitute forward-looking statements.
  • If discovered, there is no certainty that it will be commercially viable to produce any portion of the resources.

Keysight Expands Portfolio of Source/Measure Units for Test Applications Requiring High Accuracy, High Resolution and Measurement Flexibility

Retrieved on: 
Wednesday, January 13, 2021
Mobile, Wireless, Networks, Internet, Hardware, Electronic design automation, Technology, Other Manufacturing, Semiconductor, Satellite, Engineering, Other Technology, Telecommunications, Manufacturing, Applied sciences, Metrology, Academic disciplines, Branches of science, Accuracy and precision, Arithmetic, Numerical analysis, Measurement, Keysight, Significant figures, Source measure unit

Keysight offers a wide range of SMU instruments, which are categorized into four areas: precision, application specific, general-purpose and basic.

Key Points: 
  • Keysight offers a wide range of SMU instruments, which are categorized into four areas: precision, application specific, general-purpose and basic.
  • It supports accurate and precise measurement up to 210 V / 315 mA with resolution down to 500 nV / 10 fA.
  • Their seamless current measurement ranging function reduces test duration by eliminating the time it takes to change the range and expands the dynamic range to cover four measurement ranges.
  • "We have leveraged our deep SMU expertise and the latest electronic technologies to create a family of high precision PXIe modular SMUs.

GoldMining Files Technical Report for Its Yarumalito Gold-Copper Project, Colombia

Retrieved on: 
Tuesday, June 16, 2020
Arithmetic, Physical sciences, Chemistry, Fields of mathematics, Computer arithmetic, Rounding, Theory of computation, Significant figures, Copper

All quantities are rounded to the appropriate number of significant figures; consequently, sums may not add up due to rounding.

Key Points: 
  • All quantities are rounded to the appropriate number of significant figures; consequently, sums may not add up due to rounding.
  • The corresponding amounts disclosed herein and in the Technical Report have been adjusted by an immaterial amount since the date of such press release.
  • Paulo Pereira, President of GoldMining Inc. has reviewed and approved the technical information contained in this news release.
  • Through its disciplined acquisition strategy, GoldMining now controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, U.S.A., Brazil, Colombia and Peru.

GoldMining announces exercise of all January 2020 warrants

Retrieved on: 
Thursday, January 30, 2020
Arithmetic, Academic disciplines, Fields of mathematics, Economic geology, Mineral economics, Mathematics, Mineral resource estimation, Rounding, Significant figures

There is no certainty that all or any part of the mineral resources will be converted into mineral reserves.

Key Points: 
  • There is no certainty that all or any part of the mineral resources will be converted into mineral reserves.
  • Please refer to the technical report for each respective project, as referenced herein, for detailed information respecting each individual project.
  • All quantities are rounded to the appropriate number of significant figures; consequently, sums may not add up due to rounding.
  • Paulo Pereira, President of GoldMining Inc. has reviewed and approved the technical information contained in this news release.

Precision For Medicine Expands Into Central And Southeastern Europe; Surpasses 300 Employees Throughout UK And EU

Retrieved on: 
Tuesday, September 25, 2018
Medicine, Biomarkers, Clinical medicine, Biology, Arithmetic, Numerical analysis, Evidence-based medicine, Precision medicine, Systems biology, Significant figures

Commenting on Precision for Medicine's growth, President Chad Clark remarked, "Argint International is an ideal fit with Precision for Medicine.

Key Points: 
  • Commenting on Precision for Medicine's growth, President Chad Clark remarked, "Argint International is an ideal fit with Precision for Medicine.
  • "We are thrilled to be joining the Precision for Medicine family," said Agnes Pinnel, CEO of Argint International.
  • Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively.
  • Precision for Medicine is part of Precision Medicine Group, with more than 1,450 employees in 25 locations in the US, Canada, and Europe.

Precision For Medicine Expands Into Central And Southeastern Europe; Surpasses 300 Employees Throughout UK And EU

Retrieved on: 
Tuesday, September 25, 2018
Medicine, Biomarkers, Clinical medicine, Biology, Arithmetic, Numerical analysis, Evidence-based medicine, Precision medicine, Systems biology, Significant figures

Commenting on Precision for Medicine's growth, President Chad Clark remarked, "Argint International is an ideal fit with Precision for Medicine.

Key Points: 
  • Commenting on Precision for Medicine's growth, President Chad Clark remarked, "Argint International is an ideal fit with Precision for Medicine.
  • "We are thrilled to be joining the Precision for Medicine family," said Agnes Pinnel, CEO of Argint International.
  • Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively.
  • Precision for Medicine is part of Precision Medicine Group, with more than 1,450 employees in 25 locations in the US, Canada, and Europe.